EUVIMEDEUVIMED entdecken
Open Access

Association of Pathogenic/Likely Pathogenic Inherited Cardiomyopathy Variants With Heart Failure

Naman S Shetty, Mokshad Gaonkar, Akhil Pampana, Nirav Patel, April P Carson, Bernhard Haring, Bruce M Psaty, Charles Kooperberg, Eric Boerwinkle, Jerome I Rotter, João A C Lima, Jorge R Kizer und 11 weitere

Mayo Clinic Proceedings · 2025-11 · 100 (11) · 1948-1955

DOI: 10.1016/j.mayocp.2025.01.021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Mayo Clinic Proceedings, 2025-11. Verfasst von Naman S Shetty und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA. Hauptthemen laut MEDLINE: Heart Failure, Cardiomyopathies. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, WHI NIH HHS, NCATS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE: To evaluate the prevalence of pathogenic/likely pathogenic inherited cardiomyopathy variants and their association with heart failure in the (TOPMed) TransOmic for Precision of Medicine cohorts. METHODS: A retrospective cohort study using the TOPMed cohorts, including multi-ancestry US adults (≥18 years of age) with sequencing data, was conducted. Pathogenic/likely pathogenic inherited cardiomyopathy variant carrier status was determined based on ClinVar variants classified with two or more stars of evidence. Individuals without pathogenic/likely pathogenic variants were used as the reference group. The primary outcome was heart failure , adjudicated by an expert panel. Cox proportional hazards models assessed the association between carrier status and heart failure risk, adjusting for sex, study cohort, coronary artery disease, and genetic ancestry. Age was used as the timescale to account for the effect of variants since birth, and interval censoring was used to handle the uncertainty in the timing of heart failure events. RESULTS: Among 30,977 individuals (median age, 61.0 years; 71.3% female; 37.0% non-European ancestry), 229 (0.7%) were identified as pathogenic/likely pathogenic inherited cardiomyopathy variant carriers. There were 3,298 events of heart failure (35 in carriers and 3,263 in non-carriers). The heart failure incidence rate was higher in variant carriers (2.06 per 1000 person-years) compared with noncarriers (1.40 per 1000 person-years), with an adjusted hazard ratio of 1.68 (95% CI, 1.29-2.22). CONCLUSION: Approximately 1 in 140 US adults carry a cardiomyopathy variant, which increases heart failure risk. Targeted genetic screening may facilitate early identification and preventive interventions to reduce heart failure risk in carriers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureCardiomyopathiesHumansFemaleMaleMiddle AgedRetrospective StudiesUnited StatesAdultAgedGenetic Predisposition to DiseasePrevalence

Autor:innen und Institutionen

  • Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, USA.
  • Department of Medicine, University of Mississippi Medical Center, Jackson, MS, USA.
  • Department of Medicine III, Saarland University Hospital, Homburg, Saarland, Germany; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York, New York, USA.
  • Cardiovascular Health Research Unit, Department of Medicine, Department of Epidemiology, Department of Health Systems and Population Health, University of Washington, Seattle, WA, USA.
  • Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.

Förderung

  • NHLBI NIH HHS
  • WHI NIH HHS
  • NCATS NIH HHS
  • NHGRI NIH HHS
  • NIDDK NIH HHS
  • NIMHD NIH HHS
  • NIEHS NIH HHS
  • NIA NIH HHS

Zitieren

APA

Shetty, N. S., Gaonkar, M., Pampana, A., Patel, N., Carson, A. P., Haring, B., Psaty, B. M., Kooperberg, C., Boerwinkle, E., Rotter, J. I., Lima, J. A. C., Kizer, J. R., Martin, L. W., Taylor, K. D., Hall, M. E., Fornage, M., Shah, S. J., Rich, S. S., Vasan, R. S., …, & Arora, P. (2025). Association of Pathogenic/Likely Pathogenic Inherited Cardiomyopathy Variants With Heart Failure. Mayo Clinic Proceedings, 100(11), 1948-1955. https://doi.org/10.1016/j.mayocp.2025.01.021

Vancouver

Shetty NS, Gaonkar M, Pampana A, Patel N, Carson AP, Haring B, et al. Association of Pathogenic/Likely Pathogenic Inherited Cardiomyopathy Variants With Heart Failure. Mayo Clinic Proceedings. 2025;100(11):1948-1955. doi:10.1016/j.mayocp.2025.01.021

BibTeX
@article{Shetty2025,
  author = {Shetty, Naman S and Gaonkar, Mokshad and Pampana, Akhil and Patel, Nirav and Carson, April P and Haring, Bernhard and Psaty, Bruce M and Kooperberg, Charles and Boerwinkle, Eric and Rotter, Jerome I and Lima, João A C and Kizer, Jorge R and Martin, Lisa Warsinger and Taylor, Kent D and Hall, Michael E and Fornage, Myriam and Shah, Sanjiv J and Rich, Stephen S and Vasan, Ramachandran S and Nassir, Rami and Li, Peng and Arora, Garima and Arora, Pankaj},
  title = {Association of Pathogenic/Likely Pathogenic Inherited Cardiomyopathy Variants With Heart Failure},
  journal = {Mayo Clinic Proceedings},
  year = {2025},
  volume = {100},
  number = {11},
  pages = {1948--1955},
  doi = {10.1016/j.mayocp.2025.01.021}
}
Kostenlos starten →